SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending with high anticipation for its SOL-1 Phase 3 superiority trial data in wet AMD, expected via webcast, alongside renewed buzz of a potential Sanofi acquisition after a previously rejected offer. The community is actively debating the binary outcome and the implications of the data release for the company's valuation or a significant takeover.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending as Hapag-Lloyd's $35 per share acquisition offer drives fervent community discussion, focusing on the potential for a short squeeze, critical Israeli government approval, and the outlook for dividends prior to the deal's anticipated late 2026 completion.

Barclays Bank Plc engages in providing commercial banking services. It offers personal, premier, business, and corporate banking products and services to its customers. Its services include current accounts, savings, investments, mortgages, loans, insurance, credit cards, and online banking. The company was founded on October 4, 1971 and is headquartered in London, the United Kingdom.

Barclays Bank PLC - iPathÂ® Series B S&P 500Â® VIX Short-Term FuturesTM ETN

iPath S&P 500 VIX Short-Term Futures ETN

VXX is trending as the market appears overextended with suppressed volatility, prompting community discussion around an imminent spike driven by upcoming Fed decisions, earnings season, and geopolitical risks, leading many to position for a potential market pullback.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is trending following its strategic acquisition of Diligent Robotics, which expands its physical AI platform into the healthcare sector, alongside notable endorsements from NVIDIA's CEO and recent analyst upgrades. The community is actively discussing its growth potential in robotics, current profitability challenges, and significant short interest contributing to its price volatility.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack In The Box is trending amidst recent weak financial performance, significant debt concerns, and the announced sale of its Del Taco subsidiary at a substantial loss as part of a broader turnaround strategy. An activist investor's increasing stake and the company's defensive 'poison pill' strategy are fueling community speculation about a potential short squeeze, with conversations divided between fears of bankruptcy and hopes for a recovery driven by new market expansion and insider confidence.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly Inc. is trending due to a massive post-earnings surge driven by strong financial results, positive guidance, and a re-framing of the company as an "Agentic AI" beneficiary, with bulls anticipating a short squeeze. This rapid ascent, however, is met with skepticism from some who highlight insider selling and fear a coming dilution, questioning the rally's durability.

SSgA Active Trust - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

The Technology Select Sector SPDR Fund (XLK) is a focal point as investors grapple with conflicting signals from strong tech earnings and growing concerns over AI's disruptive impact, fueling community debate about a potential broader sector rotation.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Infleqtion Inc. - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X is trending as its merger with quantum technology leader Infleqtion concludes with exceptionally low redemptions, preserving substantial capital and fueling intense community anticipation for its upcoming NYSE debut as INFQ, which many believe is significantly undervalued compared to peers given its strong government and space contracts.

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

BITI is trending as a primary vehicle for shorting Bitcoin, driven by a vocal community framing crypto as a "scam" with purported ties to illicit finance, and by technical indicators suggesting an impending significant market correction.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna Group is trending as community discussion intensifies around President Trump's proposal to cap credit card interest rates at 10%, with many believing Klarna's merchant-funded, 0% interest BNPL model is uniquely positioned to benefit, despite ongoing investor frustration over its stock performance and upcoming insider lockup expiration.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Analysts

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the seven brokerages that are currently covering the stock, MarketBeat Ratings...

Esperion Therapeutics (NASDAQ:ESPR) Downgraded by Wall Street Zen to "Hold"

Wall Street Zen downgraded Esperion Therapeutics from a "buy" rating to a "hold" rating in a research report on Saturday...

Zacks Research Issues Optimistic Forecast for ESPR Earnings

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) - Analysts at Zacks Research upped their Q4 2025 earnings estimates for Esperion Therapeutics in a research report issued on Tuesday, February...

Esperion Therapeutics (NASDAQ:ESPR) Raised to "Buy" at Wall Street Zen

Wall Street Zen raised Esperion Therapeutics from a "hold" rating to a "buy" rating in a research report on Saturday...

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Recommendation of "Moderate Buy" by Brokerages

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight ratings firms that are currently covering the company, Marketbeat.com...

Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Down - Should You Sell?

Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Down - Should You Sell...

What is HC Wainwright's Estimate for ESPR FY2025 Earnings?

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) - Stock analysts at HC Wainwright upped their FY2025 earnings per share (EPS) estimates for Esperion Therapeutics in a note issued to investors...

Esperion Therapeutics (NASDAQ:ESPR) Shares Down 6.3% - Here's Why

Esperion Therapeutics (NASDAQ:ESPR) Shares Down 6.3% - Here's Why...

Esperion Therapeutics (NASDAQ:ESPR) Sets New 12-Month High - Here's Why

Esperion Therapeutics (NASDAQ:ESPR) Reaches New 1-Year High - Should You Buy...

Esperion Therapeutics (NASDAQ:ESPR) Upgraded by Wall Street Zen to "Buy" Rating

Wall Street Zen upgraded shares of Esperion Therapeutics from a "hold" rating to a "buy" rating in a research note on Saturday...

Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Esperion Therapeutics Inc.

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

ESPR
Esperion Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ESPR News

ESPREsperion Therapeutics Inc.